ClearPoint Neuro (CLPT) Cash from Investing Activities Growth (3y) (2014 - 2026)
ClearPoint Neuro (CLPT) Cash from Investing Activities Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -40.94% |
| 10 | ClearPoint Neuro | 524.46 Mn | 488.86 Mn | 7.76 Mn | -67.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.20% |
| Dec 31, 2025 | -54.75% |
| Sep 30, 2025 | 31.93% |
| Jun 30, 2025 | 83.87% |
| Mar 31, 2025 | 0.36% |
| Dec 31, 2024 | -90.57% |
| Sep 30, 2024 | 54.21% |
| Dec 31, 2023 | -66.13% |
| Mar 31, 2023 | 32.11% |
| Dec 31, 2022 | 3,854.08% |
| Sep 30, 2022 | -295.63% |
| Dec 31, 2021 | -256.46% |
| Sep 30, 2021 | -123.78% |
| Jun 30, 2021 | 46.35% |
| Mar 31, 2021 | -24.66% |
| Sep 30, 2018 | 44.33% |
| Jun 30, 2018 | -246.44% |
| Mar 31, 2018 | -45.99% |
| Mar 31, 2016 | -113.44% |
| Sep 30, 2015 | -97.47% |